Effects of EED on Zn Absorption and Retention in Children From a MNP (ZEED2)

July 1, 2019 updated by: University of Colorado, Denver

Effects of Environmental Enteric Dysfunction (EED) on Zinc (Zn) Absorption and Retention in Young Children: Study 2 - Absorption of Zn From a Multi-micronutrient Powder (MNP)

The overall objective is to determine the impact of EED on total daily zinc absorption of young Bangladeshi children (18-24 months of age) in an austere setting with high rates of diarrhea, stunting, and micro-nutrient deficiencies..

Study Overview

Detailed Description

Participating children are screened for EED using the lactulose:mannitol ratio test and assigned to one of two groups: +EED or -EED. After assignment to one of the two groups, proposed subjects will be randomized to one of four supplement groups: Micronutrient powder (MNP) with 15 mg Zn, MNP with 10 mg Zn, MNP with 5 mg Zn, and MNP with 0 mg Zn. Children will receive the supplement once with a meal on Day 8 of the study. Absorption of zinc from the supplement and from other non-supplemented meals will be determined using zinc stable isotope technology.

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dhaka, Bangladesh
        • icddr,b (International Centre for Diarrheal Disease Research, Bangladesh
    • Colorado
      • Aurora, Colorado, United States, 80045
        • University of Colorado Denver

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 2 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Absence of apparent health problems that would impair ability to consume regular diet, to tolerate zinc supplements, or to comply with demands of metabolic studies
  • Length for age Z (LAZ) score between -1.5 to -3.0
  • Hg ≥ 8

Exclusion Criteria:

  • Outside age range
  • Hb < 8
  • Chronic illness
  • Zinc supplement within past 2 weeks (including for treatment of diarrhea or MNP containing zinc)
  • Severe stunting and/or severe acute malnutrition (SAM): LAZ <-3; WHZ <-3 or MUAC < 115 or edema

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Micronutrient Powder (MNP) + 15 mg Zn
1 sachet of Micronutrient Powder (MNP) + 15 mg Zn will be added to a single meal on study day 8
Children will have the supplement powder added to one meal on study day 1. Absorption of zinc from this meal will be measured using zinc stable isotope techniques.
Active Comparator: MNP + 10 mg Zn
1 sachet of MNP + 10 mg Zn will be added to a single meal on study day 8
Same as above except MNP will contain 10 mg Zn
Active Comparator: MNP + 5 mg Zn
1 sachet of MNP + 5 mg Zn will be added to a single meal on study day 8
Same as above except MNP will contain 5 mg Zn
Placebo Comparator: MNP without Zn
1 sachet of MNP without Zn will be added to a single meal on study day 8
Same as above except MNP will not contain Zn

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total daily absorbed zinc (TAZ)
Time Frame: 1 day
Measured during the meal to determine the effects of EED on zinc absorption.
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exchangeable zinc pool (EZP)
Time Frame: 1 day
Size of exchangeable Zn pool (EZP) measured with zinc isotope methods prior to the meal.
1 day
Plasma zinc
Time Frame: 1 day
Measured prior to the meal.
1 day
Alkaline phosphatase
Time Frame: 1 day
Measured prior to the meal.
1 day
Serum retinol
Time Frame: 1 day
Measured prior to the meal.
1 day
Methyl malonic acid
Time Frame: 1 day
Measured prior to the meal.
1 day
Vitamin B12
Time Frame: 1 day
Measured prior to the meal.
1 day
Serum ferritin
Time Frame: 1 day
Measured prior to the meal.
1 day
Soluble transferrin receptors
Time Frame: 1 day
Measured prior to the meal.
1 day
CRP
Time Frame: 1 day
Measured prior to the meal.
1 day
AGP
Time Frame: 1 day
Measured prior to the meal.
1 day
TNF alpha
Time Frame: 1 day
Measured prior to the meal.
1 day
Serum endocab
Time Frame: 1 day
Measured prior to the meal.
1 day
Neopterin
Time Frame: 1 day
Measured prior to the meal.
1 day
Myeloperoxidase
Time Frame: 1 day
Measured prior to the meal.
1 day
Calprotectin
Time Frame: 1 day
Measured prior to the meal.
1 day
alpha 1 antitrypsin
Time Frame: 1 day
Measured prior to the meal.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nancy F Krebs, MD, MS, University of Colorado, Denver

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2015

Primary Completion (Actual)

March 1, 2018

Study Completion (Actual)

February 1, 2019

Study Registration Dates

First Submitted

April 27, 2016

First Submitted That Met QC Criteria

April 28, 2016

First Posted (Estimate)

May 2, 2016

Study Record Updates

Last Update Posted (Actual)

July 5, 2019

Last Update Submitted That Met QC Criteria

July 1, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Environmental Enteric Dysfunction

Clinical Trials on Micronutrient Powder (MNP) + 15 mg Zn

3
Subscribe